The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Remission Induction
Academic Article Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Academic Article Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Academic Article Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
Academic Article A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Academic Article A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Academic Article A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Academic Article Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Academic Article Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Academic Article Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Academic Article Crohn's disease: step up or top down therapy.
Academic Article Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.
Academic Article Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Academic Article Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
Academic Article Natalizumab induction and maintenance therapy for Crohn's disease.
Academic Article A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
Academic Article Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Academic Article Controversies with aminosalicylates in inflammatory bowel disease.
Academic Article Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Academic Article Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Academic Article Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article An evidence-based systematic review on medical therapies for inflammatory bowel disease.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Academic Article Treatment of inflammatory bowel disease: a review of medical therapy.
Academic Article What changes in inflammatory bowel disease management can be implemented today?
Academic Article Treat the patient or treat the disease?
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
Academic Article Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Academic Article Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.
Academic Article Infliximab for induction and maintenance therapy for ulcerative colitis.
Academic Article The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Academic Article A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Academic Article Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Academic Article Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Academic Article Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Academic Article Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
Academic Article Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
Academic Article Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
Academic Article Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
Academic Article Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.
Academic Article American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Academic Article A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
Academic Article Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
Academic Article Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Academic Article Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Academic Article Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.
Academic Article Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Academic Article Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
Academic Article Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Academic Article Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Academic Article Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Academic Article Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Academic Article Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
Academic Article Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
Academic Article Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Academic Article Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Academic Article Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Academic Article Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Academic Article A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
Academic Article Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study.
Search Criteria
  • Remission Induction